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ABSTRACT 
HIV-infected patients may be affected by a variety 
of renal disorders. Portugal has a high incidence of 
HIV2 infection and a low prevalence of HIV-infected 
patients under dialysis treatment.
The aim of this study was to characterise the type 
of renal disease in Portuguese HIV-infected patients 
and to determine if HIV2 infection is associated to 
renal pathology. Only 60 of the 5158 HIV-infected 
patients followed in our hospital underwent renal 
biopsy. Clinical and laboratory data and the type of 
renal disease were reviewed.
Male gender was predominant (76.7%), as was 
Caucasian race (78.3%). Mean age was 37.9±10.6 
years. The majority had criteria for AIDS, 66% were 
on combined antiretroviral therapy and 18.3% were 
on dialysis. The predominant lesions were immune-
complex glomerulonephritis (n=19), tubulointerstitial 
nephropathy (n=12), focal segmental glomeruloscle-
rosis (n=11), followed by HIVAN (n=8). Other patterns 
(amyloidosis, vasculitis, minimal change lesion) were 
observed. Only three patients were HIV2 infected, and 
presented diabetic nephropathy, acute tubular necrosis 
and tubulointerstitial nephritis. No correlations between 
clinical findings and renal pathology were found.
In conclusion, renal disease in HIV patients has 
a broad spectrum, and renal biopsy remains the gold 
standard for establishing the diagnosis and guide 
treatment. Renal disease is not frequent in HIV2-
infected patients, and, when present, is probably 
not directly associated with HIV infection.
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INTRODUCTION 
Human immunodeficiency virus (HIV) infection was 
first described in 19811. Since then, its clinical mani-
festations have changed over the past few decades.
The first association between HIV and the kidney 
was made in 19842, when a group of investigators 
described HIV-associated nephropathy (HIVAN) as 
a focal segmental glomerulosclerosis with collapsing 
features and severe tubulointerstitial disease. This 
lesion has been considered the most common his-
tological finding in renal biopsies in HIV1 patients3-5, 
predominantly in blacks3,5-7, and has been reported 
to be the third-leading cause of end-stage renal 
disease (ESRD) among blacks aged 20 to 64, and 
the first-leading cause of ESRD in HIV1-infected 
patients living in the US6,7. Recent data suggest 
that the introduction of combined anti-retroviral 
therapy (cART) in 1996 changed the spectrum of 
renal disease, reducing the incidence of HIVAN8, 
and increasing diabetic nephropathy, hypertension 
and nephrotoxicity.
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In Portugal, in December 2009, 37201 notified HIV 
cases were found: 15685 cases of acquired immuno-
deficiency syndrome (AIDS), of which 497 were 
caused by HIV2; 17839 cases of asymptomatic infec-
tion and 3677 AIDS-complex related cases9. Portugal 
is the European country with the higher incidence 
of HIV2 infection, due to historical and socio-
economic associations with Africa10. Interestingly, HIV2 
infection is usually related with reduced incidence of 
AIDS, better survival and lower viral burden11.
Since 1982, the department of infectious diseases 
in our hospital has followed 5158 HIV patients. To 
our knowledge, no information on the prevalence of 
HIV-associated renal disorders has been detailed in 
Portugal, and only two reports in 2007 studied acute 
renal injury (AKI) in critically ill HIV-infected patients 
admitted to an Intensive Care Unit12,13. AKI was asso-
ciated with increased mortality.
This retrospective study aims to characterise the 
type of renal disease found in Portuguese HIV-infect-
ed patients and to verify whether HIV2 infection is 
associated to renal disorders. Clinical and laboratory 
records at the date of biopsy were reviewed.
PATIENTS AND METHODS 
This was a retrospective review of all biopsies 
from HIV-infected patients received by our laboratory, 
from January 1989 to January 2009. All examined 
slides contained at least six glomeruli per section. 
Tissues for optical microscopy were stained with 
haematoxylin-eosin, periodic acid Schiff, Masson’s 
trichrome, methenamine silver and Congo red.
Focal segmental glomerulosclerosis (FSGS) was 
diagnosed by glomerular scarring and fusion/efface-
ment of foot processes, without IgA deposits. At 
least one glomerulus with segmental or global 
glomerular capillary loop collapse with wrinkling of 
the basement membrane, and marked proliferation 
and hypertrophy of overlying podocytes, associated 
to noticeable tubulointerstitial disease was required 
for HIVAN diagnosis. Membranous nephropathy was 
diagnosed if there were increased thickness of capil-
lary walls, spikes and subepithelial deposits. Mem-
branoproliferative glomerulonephritis (MPGN) was 
defined when mesangial cell proliferation, double 
contours and subendothelial deposits were present-
ed. Proliferative glomerulonephritis was characterised 
by the presence of extensive endocapillary prolifera-
tion, normal capillary walls and positive immunofluo-
rescence (IMF). Mesangial proliferation with IgA 
deposits was required for IgA nephropathy identifica-
tion. Amyloidosis was detected by Congo red bire-
fringence. Tubulointerstitial disease was diagnosed 
by interstitial oedema, fibrosis, and tubular damage, 
with no glomeruli alterations.
The degrees of interstitial infiltrate, interstitial 
fibrosis and tubular atrophy was considerate mild if 
involved cortical was <30%, moderate if between 30 
to 60% and severe if >60%. Microcystic dilatation of 
renal tubules, acute tubular necrosis and the vessels 
status were noted.
IMF was performed in frozen sections, using 
labelled human immunoglobulin (IgA, IgG, IgM), C3, 
C4, C1q and fibrinogen. When no frozen fragment 
was available, indirect immunoperoxidase using 
formalin-fixed paraffin embedded section was per-
formed. The deposits by IMF were graded from 0 to 
3+ and the location described as mesangial, subepi-
thelial or subendothelial. Deposits in tubular base-
ment membranes, peritubular capillaries and inter-
stitium were checked. When required, electron 
microscopy was performed.
Clinical and laboratory data at the time of biopsy 
were obtained: age, gender, race, hepatitis B virus 
(HBV), hepatitis C virus (HCV), and others co-infections, 
intravenous drug use, cART, dialysis requirement, 
fasting plasma glucose, serum creatinine (Scr), 
24-hour proteinuria, haematuria, ANA, anti-DNA, 
ANCA, cryoglobulins, C3, C4, CD4 lymphocyte count 
and HIV RNA level. AIDS was defined by CD4 T cells 
count below 200 per μL of blood or presence of 
AIDS-defining illnesses (cachexia, cryptococcal men-
ingitis, tuberculosis, Kaposi’s sarcoma, neurological 
impairment, candidiasis of the oesophagus, invasive 
cervical cancer, life-threatening pneumonia).
Statistical analysis 
Independent variables were compared using the 
Mann-Whitney and the chi-squared tests. Univariate 
analysis was made using the Spearman test. All tests 
were performed using the SPSS system 18.0.
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RESULTS 
From January 1989 to January 2009, 4532 biopsies 
were performed in our department, 57 in HIV1 and 3 
in HIV2-infected patients. The baseline clinical charac-
teristics of HIV patients are summarised in Tables I 
and II. Male gender (76.7%) and Caucasian race (78.3%) 
were predominant. Mean age was 37.9±10.6 years. 
Co-infections and intravenous drug use were present 
in 50% and 53.3%. The majority had AIDS criteria, and 
66% were on cART. Only 18.3% were on dialysis.
Ten different histological findings were recognised. 
The histological features are summarised in Table 
III. The predominant lesion was immune-complex 
glomerulonephritis (ICGN) present in 19 patients, fol-
lowed by tubulointerstitial nephropathy (n=12), FSGS 
(n=11) and HIVAN (n=8).
1) Immune-complex glomerulonephritis (ICGN) 
This was the most common histological finding in our 
population, ascertained in 19 patients (32%): nine patients 
with MPGN; eight with proliferative glomerulonephritis; 
one with IgA nephropathy and one with membranous 
nephropathy. All patients were HIV1 positive.
1.a) MPGN type I
Renal biopsy was performed due to nephrotic 
syndrome (n=5 patients), proteinuria (n=3) and AKI 
(n=1). Mean age was 35.3±7 years, 80% had AIDS 
and 33.3% were on cART. Patients were Caucasian 
and co-infected: six had HCV (p=0.004), two had 
HCV and HBV and one had Kaposi sarcoma. All 
patients with hepatitis were intravenous drug users. 
No patients had clinical or serological signs for lupus. 
Mean Scr was low (1.9±1.1 mg/dl), and mean protei-
nuria was high (5.6±6.4 g). Haematuria was present 
in seven (78%) patients. Histology revealed mild 
interstitial fibrosis (p<0.005) and there were no micro-
cystic tubules. IMF was positive in all patients.
1.b) Proliferative glomerulonephritis
Renal biopsy was performed due to nephrotic 
syndrome (n=5 patients), proteinuria (n=2) and AKI 
(n=1). Caucasian race was predominant. Half of the 
patients were HCV co-infected and intravenous drug 
users, one patient was only intravenous drug user, 
without hepatitis. Mean Scr was low (1.7±1.3 mg/dl), 
mean proteinuria was high (6.4±6.3g), and all had 
haematuria (p=0.01). No patients had clinical or 
serological signs for lupus. Renal histology was char-
acterised by two different findings. In four (50%) 
patients, crescentic glomerulonephritis (p<0.001), 
accompanied by variable degrees of interstitial infil-
trate, fibrosis, tubular atrophy, and positive IMF for 
C3, IgM and IgA was observed. In another four 
patients, diffuse proliferative endocapillary exudative 
glomerulonephritis (Fig. 1), with hypercellularity of 
all glomeruli, no significant interstitial infiltration or 
tubular atrophy, and positive IMF for C3 and IgG 
(3/4) and for C3, C1q and IgM (1/4) were found.
1.c) IgA nephropathy
This biopsy was obtained from a 59-year-old white 
male. Glomeruli had mesangial proliferation with no 
crescents; interstitial alterations were moderate and 
there was no dilatation of tubules. IMF staining for 
IgA was predominant.
1.d) Membranous glomerulopathy state II
This biopsy was obtained from a 40-year-old white 
male, intravenous drug user and HBV co-infected. 
Renal pathology in Portuguese HIV-infected patients
Figure 1
Proliferative glomerulonephritis. Hyperplastic podocytes with red intracytoplasmic 
reabsortion droplets (Masson trichrome stain x250).
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Renal biopsy showed a mild interstitial infiltrate, 
moderate fibrosis and tubular atrophy, with no dila-
tation of tubules. IMF was not available.
2) Tubulointerstitial nephropathy 
A predominant interstitial pathology was present 
in 12 patients: three with acute tubulointerstitial 
nephropathy biopsied due to AKI, and nine with 
features of chronicity who required renal biopsy due 
to AKI (n=4), rapidly progressive renal insufficiency 
(n=2), and proteinuria (n=3). In 88.9% cART was 
used. Mean Scr was 3.9±2.7 mg/dl. HIV2 infection 
was present in one patient with chronic tubuloint-
erstitial nephropathy on cART. All patients had normal 
glomeruli and marked interstitial nephritis. Crystals 
were found in one patient that used indinavir. Chro-
nicity was correlated with age (p=0.01), interstitial 
infiltrate (p=0.006), interstitial fibrosis (p=0.002) and 
tubular atrophy (p=0.005).
3) FSGS 
This lesion was present in 11 HIV1-infected patients, 
and all biopsies were performed due to nephrotic 
syndrome (mean proteinuria 6.2±4.9g). Mean age 
was 36.2±11.7 years and Caucasian race was pre-
dominant (81.8%). HBV co-infection was present in 
one patient and HCV in five (four of these also 
intravenous drug users). Mean CD4 count was 
196±132.3 cells/mm3, mean RNA levels were 
222695.2±427068.5 copies/ml. Only one patient had 
microcystic dilatation of tubules, without collapsing 
pattern, mild interstitial fibrosis, no cellular infiltra-
tion and no staining on IMF. The others presented 
without dilatation of tubules and, overall, with mild 
degrees of infiltrate, fibrosis and tubular atrophy. 
IMF was positive with segmental deposits of C3 and 
IgM in 5/8 patients.
4) HIVAN 
This pattern (Fig. 2) was found in eight HIV1-
infected patients, and biopsies were performed due 
to nephrotic syndrome (n=2 patients), proteinuria 
(n=1), rapidly progressive renal insufficiency (n=4), 
and haematoproteinuria (n=1). Black race was pre-
dominant (75%, p=0.02), all patients had AIDS and 
only three (37.5%) were on cART. Mean age was 
35.9±7.5 years. HBV co-infection was present in one 
patient and HCV in two (these also intravenous drug 
users). All had low CD4 count (35±9cells/mm3), high 
RNA levels (530902±2508 copies/ml), heavy protei-
nuria (5.6±6.1g), advanced renal failure (Scr 4.8±2.4 
mg/dl) and 50% were on haemodialysis (p=0.01). 
Renal histology was characterised by microcystic 
distortion of the tubules (p<0.001) (Fig. 3), severe 
Figure 3
Microcystic dilatation of the tubules, that are filled with proteinaceous casts 
(PAS x250)
Figure 2
Collapsing capillaries with hyperplastic podocytes, and protein resorption 
droplets (Jones methenamine silver x400).
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lymphocyte infiltration (p=0.04), fibrosis (p<0.001) 
and tubular atrophy (p=0.004). On IMF, four patients 
had staining for C3, three had C3 and IgM and one 
had C3 and C1q.
5) AA Amyloidosis 
This was found in three HIV1-infected Caucasian 
patients, and all biopsies were performed due to 
nephrotic syndrome [mean proteinuria 9.3±4.1g 
(p=0.04)]. One patient had Crohn’s disease, one had 
pulmonary tuberculosis and one was intravenous 
drug user. Glomeruli were sclerosed and had mesan-
gial nodules. Tubular atrophy was severe (p=0.03), 
fibrosis and interstitial infiltrates were moderate. 
Scarce deposits of C3, C1q, IgG and IgM were found 
in two patients (Fig. 4).
6) Other renal diseases 
– Minimal change lesion: one HIV1-infected female 
patient with syphilis.
– Chronic glomerulonephritis: one HIV1-infected 
patient.
– Microscopic poliarteritis: two HIV1-infected 
males, pANCA+.
– Acute tubular necrosis (ATN): one HIV1-infected 
and one HIV2-infected patient.
– Diabetic nephropathy: one HIV2-infected patient.
DISCUSSION 
About 5 to 10% of HIV1-infected patients will 
develop kidney dysfunction during the course of HIV 
disease7. Introduction of cART has improved survival, 
with consequent increased prevalence of the infec-
tion. In addition, as this population is aging, other 
problems such as diabetes or hypertension may be 
responsible for kidney disease.
In 2009, the Portuguese Society of Nephrology 
registered 10,217 patients under dialysis treatment 
and only 102 (0.998%) were HIV infected14.
We studied 60 biopsied HIV patients and a variety 
of histological findings were identified: the predomi-
nant lesion was ICGN (n=19 patients), followed by 
tubulointerstitial nephritis (n=12), FSGS (n=11) and 
HIVAN (n=8).
This study raises several points. Renal lesion 
affects predominantly men. In fact, according to our 
infectious diseases department, HIV patients are 
mainly males.
Although Portugal is the European country with a 
high number of HIV2-infected patients10, only three in 
sixty patients were HIV2 infected, and all had probable 
virus unrelated lesions: chronic tubulointerstitial 
Figure 4
AA Amyloidosis (immunofluorescence stain x400).
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Table I













Hepatitis B virus infection (%) 14% (8)
Hepatitis C virus infection (%) 47.4% (27)
Intravenous drug use (%) 61.5% (32/52)
Acquired immunodeficiency syndrome (%) 89.2% (33/37) 
Highly active antiretroviral therapy (%) 70.7% (29/41)
Renal replacement therapy (%) 17.5% (10)
CD4 lymphocyte count (cells/mm) 367.2±184.2
Plasma HIV RNA level (copies/ml) 147086.4±274399.8
Serum creatinine (mg/dl) 3.1±2.6
Proteinuria (g) 5.3±6.1
Haematuria (%) 57.4% (27/47)
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nephropathy, diabetic nephropathy and acute tubular 
necrosis. HIV2 has an apparent lack of nephrotoxicity 
compared to HIV1, and perhaps it is related to its viru-
lence. HIV2 was identified in 1986, and almost 95% of 
the infected patients are referred to be long-term non-
progressors: HIV2-infected patients have slower progres-
sion of the disease, and, usually, have more time without 
opportunistic disorders and/or with high CD4 count. 
HIV2 transmission pathways are the same for HIV1, but 
the probability of the transmission is lower, for instance, 
vertical infection is very rare in this virus.
Pathogenesis of CKD in HIV1 infection seems to 
be due to an association of at least three factors: 
viral infection (that cause epithelial tubular and epi-
thelial glomerular cells deregulation by direct infec-
tion, and by indirect toxicity due to HIV1 genes nef, 
and Vpr), immune activation (that is produced by 
viral replication and its independent on viral genes) 
and genetic predisposition of the patient to renal 
disease. Pathogenesis of CKD in HIV2 infection is 
not studied. HIV2 can cause immunodeficiency but 
rarely causes kidney disease. Although HIV2 has a 
more benign natural history, the virus has a high 
number of co-receptors for entry in CD4 T cells, 
and, likewise, it is probable that the mode of HIV2 
entry into renal cells differs from HIV1. Nevertheless, 
HIV2-infected patients present capacity for IL2 pro-
duction and high lymphocyte turnover, which relates 
to its benign immune pathogenesis. Therefore, HIVAN 
is considered to be caused by HIV1 infection and 
rare cases have been described associated with HIV2 
infection.
Contrary to US and some European studies, in 
our study HIVAN was not the predominant lesion5, 
but similarly, it affected preferentially black patients, 
with low CD4 counts, high RNA levels, severe inter-
stitial damage and worse renal function3-7. Comparing 
the clinical characteristics of HIVAN and FSGS, no 
differences were found concerning age and gender. 
Black race was predominant in HIVAN, as opposed 
to Caucasian race in FSGS; HCV infection was com-
mon in FSGS, as the use of cART. Scr and dialysis 
requirement were higher in HIVAN.
Nowadays, it is a point of discussion whether 
HIVAN and FSGS are identical or different disorders. 
According to the Columbia classification, collapsing 
glomerulopathy is considered to be a variant of FSGS. 
However Barisoni et al. proposed that it should be 
a distinct podocytopathy15. This entity is character-
ised by hyperplastic and hypertrophic podocytes, 
contrary to FSGS where podocytopaenia is the rule. 
The same author, in 1999, evidenced the abnormal 
maturation and differentiation of podocytes in both 
idiopathic collapsing glomerulopathy and HIVAN16. 
From then, the direct effect of HIV1 on those cells 
has been studied, but the pathogenesis of HIVAN 
still remains to be elucidated. It is difficult to detect 
HIV1 antigens in tissue17; HIV1 genes expression in 
renal cell is a prerequisite for the development of 
HIVAN18 and it has been shown that nef is able to 
induce molecular alterations that transform the podo-
cyte phenotype19, with loss of cell cycle quiescence 
and differentiation anomalies in glomeruli. Protein 
nef evolved to help HIV1 escape host immunity by 
downregulating key cell surface receptors on lym-
phocytes, and major histocompatibility complex class 
I. The route by which HIV1 enters renal cells is not 
clear, as tubular cells do not express the classic 
receptors for HIV1; nevertheless, Hatsukari et al. 
have demonstrated the DEC-205 receptors expres-
sion, which mediates internalisation of the virus20. 
Still, the origin of the highly proliferating glomerular 
cells in HIVAN is also not understood: Bariety et al. 
showed that parietal epithelial cells do exist along 
a normal human Bowman’s capsule and do have 
the ability to divide22. Others identified a population 
of renal progenitors CD133+CD24+, exhibiting 
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Caucasian race (%) 100%
Age (yr) 45±19.9
Hepatitis B virus infection (%) 0%
Hepatitis C virus infection (%) 0%
Intravenous drug use (%) 100%
Acquired immunodeficiency syndrome (%) 0% 
Highly active antiretroviral therapy (%) 33.3% (1)
Renal replacement therapy (%) 33.3% (1)
CD4 lymphocyte count (cells/mm) 499.4±78
Plasma HIV RNA level (copies/ml) NA
Serum creatinine (mg/dl) 3.7±1.1
Proteinuria (g) 1±1.7
Haematuria (%) 33.3% (1)
NA: non available
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self-renewal potential that might be responsible for 
exuberant glomerular injury repair23. It is still 
unknown why some injuries trigger podocyte damage 
with detachment from the basement membrane, while 
others stimulate their proliferation24. Therefore, it 
may be possible that other factors such as genetic 
trail, mechanical stress, or additional stimuli define 
the type of glomerular lesion. Zhong et al. demon-
strated that susceptible genetic background is impor-
tant to the development of HIVAN in transgenic 
mice25. Recently, MYH9 or missense mutations 
(S342G, I384M) in the neighbouring APOL1 gene 
have been considered to be responsible for the 
genetic susceptibility of African-Americans to HIV-
AN26. In addition, inflammatory mediators, such as 
viral proteins, cause Notch activation by TGFβ, which 
results in podocyte proliferation. The Notch receptor 
family includes four members, is anchored in the cell 
membrane, and is involved in short-range cell-cell 
communication, cell-fate decision, patterning and cell 
polarity. The Notch pathway is indispensable for 
glomerular development, and ectopic Notch activa-
tion in developing podocytes causes glomeruloscle-
rosis in developing murine kidneys and opposes 
terminal differentiation of podocytes27. The increased 
expression of Notch target protein in glomeruli of 
transgenic mice and the upregulation of cleaved 
Notch1 and Notch4 in human biopsies have been 
observed in HIVAN28. A recent study raised the 
hypothesis that in HIVAN the phenotype of tubular 
epithelial cells may change to what we call epithelial-
mesenchymal transition (EMT)21. EMT contributes to 
an aggressive tubulointerstitial lesion with formation 
of extensive fibrosis.
Renal pathology in Portuguese HIV-infected patients
Table III













Age (yr) 35.3±7 34.2±8.2 41.7±11.5 36.2±11.7 35.9±7.5 37±7.2
Male gender (%) 88.9% (8) 87.5% (7) 58.3% (7) 81.8% (9) 75% (6) 33.3% (1)
Black race (%) 0% 0% 16.7% (2) 18.2% (2) 75% (6)* 0%
HBV infection (%) 22% (2) 0% 25% (3) 9.1% (1) 12.5% (1) 0%
HCV infection (%) 88.9% (8)** 50% (4) 50% (6) 45.5% (5) 25% (2) 33.3% (1)
Intravenous drug use (%) 88.9% (8)* 62.5% (5) 58.3% (7) 55.6% (5/9) 42.9% (3/7) 50% (1/2)
AIDS (%) 80% (4/5) 100% (3/3) 88.9% (8/9) 75% (6/8) 100% (9) 66.7% (2)
HAART (%) 33.3% (2/6) 60% (3/5) 88.9% (8/9) 63.6% (7) 37.5% (3) 33.3% (1)
Renal replacement therapy (%) 0% 0% 25% (3) 0% 50% (4)* 33.3% (1)
CD4 count (cells/mm) 196.3±91.5 300±12.7 152±177.4 196±132.3 35±9 50±33.2












Serum creatinine (mg/dl) 1.9±1.1 1.7±1.3 -* 3.9±3 1.5±0.8-** 4.8±2.4* 3.7±2.4
Proteinuria (g) 5.6±6.4 6.4±6.3 1±1 -** 6.2±4.9 5.6±6.1 9.3±4.1*
Haematuria (%) 70% (7) 100%* 41.7% (5) 18.2% (2)-* 44.4% (4) 0%
Microcystic distortion (yes)2 0% 25% (2) 16.7% (2) 9% (1) 75% (6)** 0%












Severe: 6** Severe: 3*



























Severe: 7** Moderate: 3
*p<0.05 **p<0.005
HIVAN: HIV-associated nephropathy; FSGS: Focal segmental glomerulosclerosis; MPGN: Membranoproliferative glomerulonephritis; PGN: Proliferative glomerulonephritis; AA: AA 
amyloidosis; TI nephrop.: tubulointerstitial nephropathy
1 The degree of active interstitial infiltrate and interstitial fibrosis was estimated as a percentage of the cortical involved, considered mild if <30%, moderate if between 30 to 60% 
and severe if >60%. The tubular atrophy is estimated in the same manner.
2 The presence of microcystic dilatation of renal tubules were analysed; the numbers refer to number of patients with (yes) mycrocystic dilatation
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In our population, as in most European countries, 
the most common histological pattern was ICGN, 
which was associated with Caucasian race, hepatitis 
virus co-infection and intravenous drug use, namely 
heroin. In fact, these two last agents are well-known 
causes of glomerular damage in non-HIV patients39-31. 
ICGN pathogenesis is unknown, and it seems that it 
is not related to HIV1 infection itself, but instead 
related to an autoimmune event: immune abnormal 
response to viral proteins, and/or immune abnormal 
response to secondary superinfections, and/or pres-
ence of co-infections (mainly HBV and HCV). So, it 
is not the HIV1 infection itself, instead the immune 
response to the virus that gives rise to these lesions. 
Co-infections appear as confounding factors for renal 
disease in these disorders. Although all histological 
patterns were associated with low CD4 count and 
high RNA levels, these associations were more obvi-
ous in HIVAN pattern. The interstitial area was notably 
different from HIVAN, as no mycrocystic dilatation 
was seen and only mild damage was evident. Gern-
tholtz et al. have described a pattern of mesangial 
and paramesangial proliferation, denominated “ball-
in-cup”32. Swanepoel et al. also described this lesion 
as a variant of post-infectious or membranous 
glomerulonephritis, and described other variants, the 
“central sclerosis” variant and “foetal glomeruli”33, 
that we did not find. Associations between HIV infec-
tion and IgA nephropathy in Caucasian males have 
been made. Indeed, immune complexes containing 
IgA are frequently seen in these individuals4 and 
polyclonal increase in serum IgA is a common feature 
of AIDS. We found only one case.
Tubulointerstitial nephropathy was associated with 
cART, raising the question of nephrotoxicity. In 
accordance, this lesion is usually induced by medica-
tion. Nevertheless, we cannot exclude that HIV can 
produce an interstitial disease on its own.
Some unexpected patterns were found. Secondary 
amyloidosis is an uncommon cause for renal disease 
in HIV patients. Chronic inflammation due to Crohn’s 
disease and tuberculosis justified this finding in two 
patients. In the third, chronic soft tissue infection 
related to intravenous drug use; skin popping34, was 
probably the cause. Of note, HIV1 disease induces a 
permanent immune activation and elevation of inflam-
matory mediators. In this scenario, AA amyloidosis 
might develop. Minimal change lesion, a T-cell 
mediated disease35, and microscopic poliarteritis were 
also unexpected histological findings. The role of the 
virus in these non-HIV-related nephropathies remains 
unclear.
ATN is the most common cause of intrinsic AKI 
in HIV patients. This pattern was only diagnosed in 
two patients, as biopsies are only performed if a 
suspected ATN remains after four weeks.
The apparent low number of kidney biopsies may 
be explained by the fact that, in our hospital, the 
majority of acute renal dysfunction cases seen in HIV 
are linked to ATN. Arendse et al. also highlight the 
high frequency of ATN and its importance in survival 
on AKI in HIV-positive patients36. In addition to sus-
pected ATN, some patients, when referred to our 
department, already have reduced-sized kidneys, 
contraindicating kidney biopsy. However, renal failure 
may not be frequent in Lisbon/Portugal, as only 0.99% 
of dialysis patients are HIV infected. Obviously, one 
might argue that the majority of patients died before 
initiating dialysis. According to Institute Ricardo Jorge, 
in 2009, 1273/15020 (48.4%) died, 41.2% from oppor-
tunistic infection including tuberculosis, not justifying 
the reduced number of HIV patients in dialysis. Unfor-
tunately, we have no information regarding the out-
come in the majority of the patients, and, in the 
majority, the length of HIV infection was not recorded. 
It would be interesting to discuss if time alters neph-
ropathy characteristics.
In conclusion, in our population the three major 
histological patterns found were ICGN, tubulointer-
stitial nephritis and FSGS. HIVAN was the fourth 
lesion and related to black race. No correlations 
between data and pattern of renal disease were 
seen; therefore it is not possible to predict the renal 
disease based on clinical criteria. Renal biopsy 
remains the gold standard for establishing the diag-
nosis. It appears that HIV2-infected patients have 
an unexplained low incidence of renal disorders. It 
is highly probable that a variety of factors other than 
virus related may be necessary for kidney damage 
and/or development of kidney failure.
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